Back
Allegion PLC Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
39
ALLE
Allegion PLC
Last Price:
$130.41
Seasonality Move:
3.85%
Buy
53
ALNY
Alnylam Pharmaceuticals
Last Price:
$269.17
Seasonality Move:
3.3%
Sell
39
Allegion PLC (ALLE)
is a Sell
Is Allegion PLC a Buy, Sell or Hold?
-
The current Allegion PLC [ALLE] share price is $129.59. The Score for ALLE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
ALLE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $280.96. The Score for ALNY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALLE Stock Price Chart
What is Allegion PLC's stock price today?
-
The Allegion PLC share price today is $129.59Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALLE is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $280.96The current trend is moderately bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
ALLE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 52.74 | Buy |
| Chaikin Money Flow: | -374690 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (125.5 - 129.82) | Buy |
| Bollinger Bands (100): | (128.01 - 139.45) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.18 | Buy |
| Relative Strength Index (14 RSI): | 64.02 | Buy |
| Chaikin Money Flow: | -956276 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (237.98 - 264.74) | Buy |
| Bollinger Bands (100): | (240.44 - 271.42) | Buy |
ALLE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 128.2 | Buy |
| 20-day SMA: | 127.57 | Buy |
| 50-day SMA: | 129.41 | Buy |
| 200-day SMA: | 132.94 | Sell |
| 8-day EMA: | 128.4 | Buy |
| 20-day EMA: | 128.1 | Buy |
| 50-day EMA: | 129.7 | Sell |
| 200-day EMA: | 131.44 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 262.64 | Buy |
| 20-day SMA: | 251.27 | Buy |
| 50-day SMA: | 258.44 | Buy |
| 200-day SMA: | 252.16 | Buy |
| 8-day EMA: | 267.69 | Buy |
| 20-day EMA: | 258.45 | Buy |
| 50-day EMA: | 256.39 | Buy |
| 200-day EMA: | 243.81 | Buy |
Allegion PLC Earnings Growth & ALLE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.36 per share, an increase this year of $0.36 per share, and an increase next year of $0.62 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Allegion PLC Technical Analysis
| Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||